Cannabis doesn’t fit neatly into a single category. It crosses multiple classification systems at once: as a drug, it acts as a depressant, stimulant, and hallucinogen simultaneously. Legally, it’s a Schedule I controlled substance under U.S. federal law, though that status is under active review. Botanically, it belongs to the same plant family as hops. The answer depends entirely on which framework you’re asking about, so here’s how weed is categorized across all of them.
Drug Type: Depressant, Stimulant, and Hallucinogen
Most drugs fall into one of three categories based on how they affect the central nervous system: depressants slow it down, stimulants speed it up, and hallucinogens alter sensory perception. Cannabis is unusual because it does all three. The Australian Department of Health lists it in every category, and most pharmacology references agree.
As a depressant, cannabis slows the messages traveling between your brain and body. This is why it can make you feel relaxed, sleepy, or physically heavy. “Depressant” doesn’t mean it makes you feel depressed. It refers to the slowing effect on your nervous system, similar to alcohol or sedatives.
As a stimulant, it can increase your heart rate, elevate your mood, and make you feel more alert or talkative, especially in lower doses or with certain strains. As a hallucinogen, it can distort your senses: colors may seem brighter, time may feel like it’s passing differently, and sounds might seem more intense. At higher doses, some people experience mild visual or auditory distortions.
Which effect dominates depends on the dose, the specific product, and individual biology. This is part of why people describe such different experiences with the same substance. One person feels sedated while another feels energized, and both are responding to real pharmacological effects.
Federal Legal Classification: Schedule I
Under the U.S. Controlled Substances Act, cannabis is currently classified as a Schedule I substance. That’s the most restrictive category, shared with heroin and LSD. Schedule I means the federal government considers it to have a high potential for abuse and no currently accepted medical use. This classification has been in place since 1970.
That may change soon. In May 2024, the Department of Justice proposed moving cannabis to Schedule III, which would acknowledge that it has accepted medical uses and a lower potential for abuse than Schedule I or II drugs. Schedule III is where substances like testosterone and certain codeine formulations sit. The Department of Health and Human Services supported the move, stating that cannabis has a potential for abuse lower than Schedule I and II substances and that its abuse may lead to moderate or low physical dependence or high psychological dependence.
A formal hearing on the proposed rescheduling began in December 2024. If the transfer is finalized, manufacturing, distribution, and possession of cannabis would still be subject to federal criminal law, but the regulatory framework would be significantly less restrictive. Schedule III status would also open the door to easier research access and could change how cannabis businesses are taxed.
The Hemp vs. Marijuana Legal Split
U.S. law draws a hard line within cannabis based on one number: 0.3% THC. The 2018 Farm Bill defined “hemp” as any cannabis plant (or product derived from it) containing no more than 0.3% delta-9 THC on a dry weight basis. Hemp is federally legal and regulated as an agricultural product. Anything above that threshold is legally “marijuana” and falls under controlled substance rules.
This distinction is purely legal, not botanical. A hemp plant and a marijuana plant can look identical. The difference is the concentration of THC, the compound responsible for the high. CBD products sold legally in the U.S. are typically derived from hemp to stay under the 0.3% threshold.
State-Level Categories
While the federal government treats cannabis as Schedule I, states have created their own categories. As of May 2024, 38 states plus Washington, D.C., Puerto Rico, Guam, and the U.S. Virgin Islands allow medical marijuana use. Twenty-four states, D.C., Guam, and the Northern Mariana Islands have legalized recreational (often called “adult-use”) cannabis for people 21 and older.
States that have legalized recreational use generally allow adults to possess specific quantities and have set up regulated retail systems for sales. Medical-use states require a qualifying condition and some form of authorization from a healthcare provider. A handful of states still prohibit cannabis in all forms. This patchwork means the practical category weed falls into depends heavily on where you are.
International Classification
Internationally, cannabis is controlled under the 1961 United Nations Single Convention on Narcotic Drugs. It’s listed in both Schedule I and Schedule IV of that treaty, with Schedule IV being reserved for substances the UN considers particularly liable to abuse with limited therapeutic value. This international classification influences drug policy in most countries worldwide, though enforcement and interpretation vary enormously.
Chemical Classification
From a chemistry standpoint, the active compounds in cannabis are called cannabinoids. Researchers have identified more than 100 different cannabinoids in the plant. The two most studied are THC, the primary psychoactive compound that produces the high, and CBD, which does not produce a high and is being studied for a range of potential therapeutic effects.
Beyond those two, scientists have organized the plant’s cannabinoids into 11 chemical classes, each named after a lead compound. These include CBG (cannabigerol), CBC (cannabichromene), and CBN (cannabinol), among others. Each has distinct properties, and some are being investigated for anti-inflammatory, pain-relieving, or neuroprotective effects. The specific mix of cannabinoids in a given cannabis product shapes its overall effects.
The FDA has approved one cannabis-derived medication: a purified CBD product used to treat severe seizure disorders in patients two years and older. Three synthetic cannabinoid medications are also approved, all used to manage nausea from chemotherapy or appetite loss in AIDS patients. Cannabis itself, as a whole plant, has no FDA approval for any condition.
Botanical Classification
As a plant, cannabis belongs to the family Cannabaceae, which it shares with hops (the plant used to flavor beer) and eight other genera. Its full species name is Cannabis sativa L. The familiar terms “sativa” and “indica” that you see in dispensaries loosely correspond to real botanical subspecies: C. sativa subsp. sativa (lower THC) and C. sativa subsp. indica (higher THC), with 0.3% THC as the dividing line. DNA analysis supports this separation.
Within each subspecies, botanists further distinguish between domesticated varieties (bred by humans for specific traits) and wild-type varieties that grow without cultivation. The “sativa vs. indica” labels on commercial products, however, don’t reliably map onto these botanical categories. Most modern cannabis has been so extensively crossbred that the dispensary labels reflect marketing more than genetics.